Aurobindo gets nod in Australia for anti-hypertension tablets

Agencies
Posted: Monday, Jun 15, 2009 at 1623 hrs IST
Updated: Monday, Jun 15, 2009 at 1623 hrs IST

Font Size

Feedback

Discuss

GSK Pharma Q3 profit rises 7%Dr Reddy's Q2 net up 3 fold at Rs 240 cr Piramal Healthcare Q2 net up 45 pct Ranbaxy hails US court ruling on Valcyte patent

Mumbai: Drug maker Aurobindo Pharma said its Australia-based subsidiary has received the approval from the Australian drug regulator for registration of anti-hypertension tablets.

"Aurobindo Pharma Australia has received approval from Therapeutic Goods Administration (TGA) for the registration of Amlodipine Besylate tablets," the Hyderabad-based drug maker said in a filing to the Bombay Stock Exchange.

Amlodipine bseylate tablets are used for the treatment of hypertension and "can be used as the sole agent to control blood pressure in the majority of patients."

This is Aurobindo's fourth approval from TGA, Australia.

Shares of Aurobindo Pharma were trading at Rs 475, down 0.39 per cent in the afternoon trade on the BSE.

Post Comments

Comments: (Limit 3,000 characters)

Name		Message
Email ID
Subject

TERMS OF USE:
The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).

I agree to the terms of use.